missing translation for 'onlineSavingsMsg'
Learn More

Phospho-MEK1 (Thr292) Mouse Monoclonal Antibody, Proteintech

Mouse Monoclonal Antibody

1445.86 SEK - 3875.74 SEK

Specifications

Antigen MEK1 (Thr292)
Clone 2D7A8
Concentration 1000 μg/mL
Applications Western Blot, ELISA, Flow Cytometry (Intracellular Staining)
Classification Monoclonal
View More Specs

Products 2
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
30238126
View Documents
Proteintech
67873-1-IG-20UL
20 μL
1445.86 SEK
20µL
Please to purchase this item. Need a web account? Register with us today!
30238137
View Documents
Proteintech
67873-1-IG-100UL
100 μL
3875.74 SEK
100µL
Please to purchase this item. Need a web account? Register with us today!
Description

Description

The Phospho-MEK1 (Thr292) antibody from Proteintech is a mouse monoclonal antibody generated with peptide of human Phospho-MEK1 (Thr292). This antibody recognizes human, mouse, rat antigen. The Phospho-MEK1 (Thr292) antibody has been validated for the following applications: WB, ELISA, FC (Intra) analysis.
Specifications

Specifications

MEK1 (Thr292)
1000 μg/mL
Monoclonal
Liquid
RUO
5604
Peptide
Primary
Store at -20°C. Stable for one year after shipment.
2D7A8
Western Blot, ELISA, Flow Cytometry (Intracellular Staining)
Unconjugated
Mouse
Human, Mouse, Rat
MAPKK1; MEK1; MKK1; PRKMK1
IgG1
Protein G purification
Monoclonal Antibody
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.